BREAST CANCER METASTATIC
Clinical trials for BREAST CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER METASTATIC trials appear
Sign up with your email to follow new studies for BREAST CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo shows promise for Hard-to-Treat breast cancer
Disease control CompletedThis study tested a new treatment combination for people with advanced breast cancer that has stopped responding to standard therapies. The treatment uses a personalized vaccine (SV-BR-1-GM) plus an immunotherapy drug (retifanlimab) to help the immune system fight the cancer. The…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: BriaCell Therapeutics Corporation • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New combo shows promise for tough breast cancer
Disease control CompletedThis study tested two treatment plans for people with advanced HR+/HER2- breast cancer that is aggressive. One group got a drug called abemaciclib plus hormone therapy, while the other group started with chemo followed by the same combo. The goal was to see which approach works b…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
New pill shows promise against inherited breast cancer
Disease control CompletedThis study tested a targeted drug called olaparib against standard chemotherapy in 302 people with advanced breast cancer who have inherited BRCA1 or BRCA2 gene mutations. The goal was to see if olaparib could slow cancer growth better than chemo. Participants received either ola…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 13:50 UTC